Ocera Therapeutics, Inc.

675 James S McDonnell Blvd, Hazelwood, Missouri, United States

Clinical Trials

7 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

18.2%

Phase 2

9.1%

Phase 3

9.1%

Trial Status Distribution

Active, not recruiting

63.6%

Completed

27.3%

No Longer Available

9.1%

Clinical Trials

Trials sponsored by this organization (11)

OCR002-SP103 - Oral Immediate Release Study

Phase 1

Completed

interventional

Aug 201630 participants

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

Phase 2

Completed

interventional

Jan 2014231 participants

A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF AST-120 IN PATIENTS WITH NON-CONSTIPATING IRRITABLE BOWEL SYNDROME

Active, not recruiting

May 2007100 participants

A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF AST-120 IN MILD TO MODERATELY ACTIVE CROHN’S PATIENTS WITH FISTULAS

Active, not recruiting

Jan 2007240 participants

A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF AST-120 IN MILD TO MODERATELY ACTIVE CROHN’S PATIENTS WITH FISTULAS

Active, not recruiting

Sep 2006240 participants

A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF AST-120 IN MILD TO MODERATELY ACTIVE CROHN’S PATIENTS WITH FISTULAS

Active, not recruiting

Jun 2006240 participants

A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF AST-120 IN MILD TO MODERATELY ACTIVE CROHN’S PATIENTS WITH FISTULAS

Active, not recruiting

Apr 2006240 participants

A DOUBLE BLIND, RANDOMIZED, PLACEBO-CONTROLLED MULTICENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF AST-120 IN MILD TO MODERATELY ACTIVE CROHN’S PATIENTS WITH FISTULAS

Active, not recruiting

Apr 2006240 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations